Ultimovacs
A pharmaceutical company developing novel immunotherapies against cancer. Learn more
Launch date
Employees
Market cap
AUD12.1m
Enterprise valuation
(AUD19m) (Public information from Sep 2024)
Share price
NOK1.77 ULTI.OL
Company register number 996713008
Oslo Norway (HQ)
Authorizing premium user...